Just raised · Biotech & life sciences
SRTD Biotech: funding and hiring
SRTD Biotech develops selectively expressed RNA (seRNA) therapies that activate only in diseased cells, for oncology, autoimmune and fibrosis…
- €31.5M Seed
- Announced Nov 9, 2026
- Recruiter fit 38
Open roles
No public job board found yet. We check again every week, and this page updates when roles go up.
Who to contact
Reach the founder or whoever runs hiring while the headcount plan is still being written. Hiring Radar shows any company's open roles and hiring contacts in your browser.
Funding
SRTD Biotech raised €31.5M Seed, announced November 9, 2026.
Investors: Mérieux Equity Partners
Jülich-based SRTD Biotech secures €31.5 million to develop precision mRNA therapies targeting diseased cells
Company
- Industry
- Biotech & life sciences
- First seen
- Nov 9, 2026
Recruiter fit 38/100
- Recency +22
- Round size +16
- Capped at 40 until we can count their open roles
Follow SRTD Biotech
Get an email when SRTD Biotech raises again or posts three or more new roles. Only when something changes.
Other biotech startups hiring after a raise
Work at SRTD Biotech?
Add this badge to your careers page or press kit. It links back to this page.
